Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07123766

Clinical Investigation for the PoliaValve Aortic Heart Valve- India

A Prospective, Multicenter, Single-Arm Study With Objective Performance Criteria Evaluating the Efficacy and Safety of PoliaValve® Artificial Heart Valve

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Suzhou Hearthill Medical Technology Co.,LTD · Industry
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to conduct a clinical investigation of the HeartHill PoliaValve Aortic Valve to collect evidence on the device's safety and performance.

Detailed description

The PoliaValve is indicated as a replacement for diseased, damaged, or malfunctioning native aortic heart valve via open heart surgery. The study is a single-arm, open label, non-randomized multi- center clinical trial. Up to 10 sites in the country of India will enroll up to 50 patients. These patients will follow the study schedule for 1 year after implantation.

Conditions

Interventions

TypeNameDescription
DEVICEPoliaValve (Aortic)Aortic Valve Replacement

Timeline

Start date
2025-11-15
Primary completion
2027-12-30
Completion
2027-12-30
First posted
2025-08-14
Last updated
2025-08-14

Source: ClinicalTrials.gov record NCT07123766. Inclusion in this directory is not an endorsement.